CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells. 1999

T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Japan.

The CD9 molecule is expressed on human extravillous trophoblasts, which invade the endometrium during implantation and placentation. To elucidate the role of CD9 in trophoblastic function, we investigated the expression of CD9 protein and mRNA in BeWo cells, a human trophoblast-like choriocarcinoma cell line, using immunohistochemistry, Western blotting and reverse transcription-polymerase chain reaction (RT-PCR). When BeWo cells were cultured with anti-CD9 monoclonal antibodies (mAb), their invasion through the extracellular matrices was significantly enhanced in a dose-dependent manner. Cell proliferation and human chorionic gonadotrophin production were unaffected. On the other hand, culture in the presence of mAb against integrins alpha3, alpha5 and beta1, which partially block the interaction with the extracellular matrices, inhibited BeWo cell invasion. Anti-CD9 monoclonal antibody had a stimulatory effect on BeWo cell invasion in the presence of anti-integrin alpha3 antibody. In contrast, it had no effect in the presence of mAb against integrins alpha5 and beta1, which were also highly expressed on BeWo cells. These findings suggest that CD9 has a function connected with the invasive properties of BeWo cells, which is partially mediated by integrin alpha5beta1. This may relate to the involvement of CD9 in trophoblastic invasion.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014327 Trophoblasts Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA). Cytotrophoblasts,Syncytiotrophoblasts,Trophoblast,Cytotrophoblast,Syncytiotrophoblast

Related Publications

T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
June 2008, Placenta,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
January 1990, Journal of immunology (Baltimore, Md. : 1950),
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
November 2016, Placenta,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
January 2001, Placenta,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
September 2012, Placenta,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
June 2008, The Journal of membrane biology,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
January 2000, Journal of endocrinological investigation,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
April 2005, Placenta,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
May 2010, Archives of gynecology and obstetrics,
T Hirano, and T Higuchi, and H Katsuragawa, and T Inoue, and N Kataoka, and K R Park, and M Ueda, and M Maeda, and H Fujiwara, and S Fujii
May 2017, Prostaglandins, leukotrienes, and essential fatty acids,
Copied contents to your clipboard!